[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$ftOd9dbcjHu14Do81NnapxSuHskUU__frmS_WsWx0Hxg":3},{"sponsor":4,"sponsorVariants":5,"totalTrials":6,"truncated":7,"activeTrials":8,"phase3Count":9,"totalEnrollment":10,"activePrograms":9,"nonDrugCount":11,"topConditions":12,"upcomingReadouts":32,"phaseBuckets":43,"rows":50},"Catharina Ziekenhuis Eindhoven",[4],81,false,8,2,18376,67,[13,16,19,21,24,26,28,30],{"name":14,"count":15},"Coronary Artery Disease",6,{"name":17,"count":18},"Heart Failure",4,{"name":20,"count":18},"Atrial Fibrillation",{"name":22,"count":23},"Intubation Complication",3,{"name":25,"count":23},"Osteoporosis",{"name":27,"count":23},"Cardiac Output, High",{"name":29,"count":23},"Acute Myocardial Infarction",{"name":31,"count":9},"External Cephalic Version",[33,38],{"nctId":34,"briefTitle":35,"date":36,"intervention":37},"NCT04389086","Induction Chemotherapy for Locally Recurrent Rectal Cancer","2024-03-01","Combination drug",{"nctId":39,"briefTitle":40,"date":41,"intervention":42},"NCT05405270","Predicting Response In Cervical Intraepithelial Neoplasia to Topical Imiquimod Treatment","2024-12","Imiquimod",[44,45,46,47,48,49],"EARLY_PHASE1","PHASE1","PHASE2","PHASE3","PHASE4","NA",[51,76,101,128,154,179,201,228,257,275,293,319,348,374,399,424],{"intervention":37,"totalTrials":52,"cells":53},1,{"EARLY_PHASE1":54,"PHASE1":57,"PHASE2":59,"PHASE3":61,"PHASE4":72,"NA":74},{"trials":55,"activeCount":56},[],0,{"trials":58,"activeCount":56},[],{"trials":60,"activeCount":56},[],{"trials":62,"activeCount":52,"soonestReadout":36},[63],{"nctId":34,"briefTitle":35,"status":64,"phases":65,"primaryCompletion":36,"completion":66,"start":67,"enrollment":68,"conditions":69,"interventions":71},"RECRUITING",[47],"2030-03-01","2020-11-13",364,[70],"Recurrent Rectal Cancer",[37],{"trials":73,"activeCount":56},[],{"trials":75,"activeCount":56},[],{"intervention":42,"totalTrials":52,"cells":77},{"EARLY_PHASE1":78,"PHASE1":80,"PHASE2":82,"PHASE3":84,"PHASE4":86,"NA":88},{"trials":79,"activeCount":56},[],{"trials":81,"activeCount":56},[],{"trials":83,"activeCount":56},[],{"trials":85,"activeCount":56},[],{"trials":87,"activeCount":56},[],{"trials":89,"activeCount":52,"soonestReadout":41},[90],{"nctId":39,"briefTitle":40,"status":64,"phases":91,"primaryCompletion":41,"completion":92,"start":93,"enrollment":94,"conditions":95,"interventions":100},[],"2026-12","2022-06-01",410,[96,97,98,99],"Cervical High Grade Squamous Intraepithelial Lesion","Cervical Intraepithelial Neoplasia Grade 2\u002F3","CIN 2\u002F3","Cervical Intraepithelial Neoplasia",[42],{"intervention":102,"totalTrials":52,"cells":103},"Erythropoietin subcutaneously and Iron intravenously",{"EARLY_PHASE1":104,"PHASE1":106,"PHASE2":108,"PHASE3":110,"PHASE4":112,"NA":126},{"trials":105,"activeCount":56},[],{"trials":107,"activeCount":56},[],{"trials":109,"activeCount":56},[],{"trials":111,"activeCount":56},[],{"trials":113,"activeCount":56},[114],{"nctId":115,"briefTitle":116,"status":117,"phases":118,"primaryCompletion":119,"completion":119,"start":120,"enrollment":121,"conditions":122,"interventions":125},"NCT02210949","Pre-operative Treatment With Erythropoietin and Iron Supplement in Cardiac Surgery","TERMINATED",[48],"2017-04","2014-08",7,[123,124],"Heart; Dysfunction Postoperative, Cardiac Surgery","Anemia, Iron-Deficiency",[102],{"trials":127,"activeCount":56},[],{"intervention":129,"totalTrials":52,"cells":130},"Abciximab",{"EARLY_PHASE1":131,"PHASE1":133,"PHASE2":135,"PHASE3":137,"PHASE4":139,"NA":152},{"trials":132,"activeCount":56},[],{"trials":134,"activeCount":56},[],{"trials":136,"activeCount":56},[],{"trials":138,"activeCount":56},[],{"trials":140,"activeCount":56},[141],{"nctId":142,"briefTitle":143,"status":144,"phases":145,"primaryCompletion":146,"completion":147,"start":148,"enrollment":149,"conditions":150,"interventions":151},"NCT00986050","Comparison of Drug Eluting and Bare Metal Stents With or Without Abciximab in ST Elevation Myocardial Infarction","COMPLETED",[48],"2008-05","2009-07","2006-01",907,[29],[129],{"trials":153,"activeCount":56},[],{"intervention":155,"totalTrials":52,"cells":156},"Clopidogrel",{"EARLY_PHASE1":157,"PHASE1":159,"PHASE2":161,"PHASE3":163,"PHASE4":165,"NA":177},{"trials":158,"activeCount":56},[],{"trials":160,"activeCount":56},[],{"trials":162,"activeCount":56},[],{"trials":164,"activeCount":56},[],{"trials":166,"activeCount":56},[167],{"nctId":168,"briefTitle":169,"status":144,"phases":170,"primaryCompletion":171,"completion":172,"start":173,"enrollment":174,"conditions":175,"interventions":176},"NCT00724880","Effect of Clopidogrel (Plavix) on Postoperative Bleeding in Patients Undergoing Coronary Artery Bypass Surgery.",[48],"2007-11","2007-12","2006-06",135,[14],[155,155,155],{"trials":178,"activeCount":56},[],{"intervention":180,"totalTrials":52,"cells":181},"bIAP",{"EARLY_PHASE1":182,"PHASE1":184,"PHASE2":186,"PHASE3":188,"PHASE4":197,"NA":199},{"trials":183,"activeCount":56},[],{"trials":185,"activeCount":56},[],{"trials":187,"activeCount":56},[],{"trials":189,"activeCount":56},[190],{"nctId":191,"briefTitle":192,"status":144,"phases":193,"conditions":194,"interventions":196},"NCT01010724","Efficacy and Safety Study on bIAP",[47],[14,195],"Endotoxin-mediated Complications From Cardiopulmonary Bypass Surgery",[180],{"trials":198,"activeCount":56},[],{"trials":200,"activeCount":56},[],{"intervention":202,"totalTrials":52,"cells":203},"Non pegylated liposomal doxorubicin and docetaxel",{"EARLY_PHASE1":204,"PHASE1":206,"PHASE2":208,"PHASE3":222,"PHASE4":224,"NA":226},{"trials":205,"activeCount":56},[],{"trials":207,"activeCount":56},[],{"trials":209,"activeCount":56},[210],{"nctId":211,"briefTitle":212,"status":144,"phases":213,"primaryCompletion":214,"completion":215,"start":216,"enrollment":217,"conditions":218,"interventions":221},"NCT00377559","Liposomal Doxorubicin and Docetaxel in HER2 Negative Metastatic Breast Cancer",[46],"2009-11","2011-07","2006-05",70,[219,220],"Breast Cancer","Neoplasm Metastasis",[202],{"trials":223,"activeCount":56},[],{"trials":225,"activeCount":56},[],{"trials":227,"activeCount":56},[],{"intervention":229,"totalTrials":52,"cells":230},"Irinotecan",{"EARLY_PHASE1":231,"PHASE1":233,"PHASE2":235,"PHASE3":251,"PHASE4":253,"NA":255},{"trials":232,"activeCount":56},[],{"trials":234,"activeCount":56},[],{"trials":236,"activeCount":56},[237],{"nctId":238,"briefTitle":239,"status":240,"phases":241,"primaryCompletion":242,"completion":242,"start":243,"enrollment":244,"conditions":245,"interventions":248},"NCT06003998","Intraperitoneal Irinotecan With Concomitant FOLFOX and Bevacizumab","UNKNOWN",[46],"2025-01-01","2022-12-27",85,[246,247],"Colorectal Cancer","Peritoneal Metastases",[229,249,250],"FOLFOX regimen","Bevacizumab",{"trials":252,"activeCount":56},[],{"trials":254,"activeCount":56},[],{"trials":256,"activeCount":56},[],{"intervention":249,"totalTrials":52,"cells":258},{"EARLY_PHASE1":259,"PHASE1":261,"PHASE2":263,"PHASE3":269,"PHASE4":271,"NA":273},{"trials":260,"activeCount":56},[],{"trials":262,"activeCount":56},[],{"trials":264,"activeCount":56},[265],{"nctId":238,"briefTitle":239,"status":240,"phases":266,"primaryCompletion":242,"completion":242,"start":243,"enrollment":244,"conditions":267,"interventions":268},[46],[246,247],[229,249,250],{"trials":270,"activeCount":56},[],{"trials":272,"activeCount":56},[],{"trials":274,"activeCount":56},[],{"intervention":250,"totalTrials":52,"cells":276},{"EARLY_PHASE1":277,"PHASE1":279,"PHASE2":281,"PHASE3":287,"PHASE4":289,"NA":291},{"trials":278,"activeCount":56},[],{"trials":280,"activeCount":56},[],{"trials":282,"activeCount":56},[283],{"nctId":238,"briefTitle":239,"status":240,"phases":284,"primaryCompletion":242,"completion":242,"start":243,"enrollment":244,"conditions":285,"interventions":286},[46],[246,247],[229,249,250],{"trials":288,"activeCount":56},[],{"trials":290,"activeCount":56},[],{"trials":292,"activeCount":56},[],{"intervention":294,"totalTrials":52,"cells":295},"FOLFOXIRI Protocol",{"EARLY_PHASE1":296,"PHASE1":298,"PHASE2":300,"PHASE3":313,"PHASE4":315,"NA":317},{"trials":297,"activeCount":56},[],{"trials":299,"activeCount":56},[],{"trials":301,"activeCount":56},[302],{"nctId":303,"briefTitle":304,"status":240,"phases":305,"primaryCompletion":306,"completion":307,"start":308,"enrollment":309,"conditions":310,"interventions":312},"NCT04838496","Induction Chemotherapy for Locally Advanced Rectal Cancer",[46],"2025-06-01","2026-06-01","2021-06-01",128,[311],"Rectal Cancer",[294],{"trials":314,"activeCount":56},[],{"trials":316,"activeCount":56},[],{"trials":318,"activeCount":56},[],{"intervention":320,"totalTrials":52,"cells":321},"Diuretics",{"EARLY_PHASE1":322,"PHASE1":324,"PHASE2":326,"PHASE3":328,"PHASE4":330,"NA":332},{"trials":323,"activeCount":56},[],{"trials":325,"activeCount":56},[],{"trials":327,"activeCount":56},[],{"trials":329,"activeCount":56},[],{"trials":331,"activeCount":56},[],{"trials":333,"activeCount":56},[334],{"nctId":335,"briefTitle":336,"status":144,"phases":337,"primaryCompletion":338,"completion":339,"start":338,"enrollment":340,"conditions":341,"interventions":347},"NCT03395951","Mean Systemic Filling Pressure Continuous Diuretics Critical Care Patients",[],"2014-10-01","2015-01-31",18,[342,17,343,344,345,346],"Sepsis","Heart Diseases","Septic Shock","Surgery","Critically Ill",[320],{"intervention":349,"totalTrials":52,"cells":350},"Extra blood samples for determining exposure to 5-FU",{"EARLY_PHASE1":351,"PHASE1":353,"PHASE2":355,"PHASE3":357,"PHASE4":359,"NA":361},{"trials":352,"activeCount":56},[],{"trials":354,"activeCount":56},[],{"trials":356,"activeCount":56},[],{"trials":358,"activeCount":56},[],{"trials":360,"activeCount":56},[],{"trials":362,"activeCount":56},[363],{"nctId":364,"briefTitle":365,"status":240,"phases":366,"primaryCompletion":367,"completion":367,"start":368,"enrollment":369,"conditions":370,"interventions":373},"NCT05620524","Therapeutic Oncolytic Monitoring as a Tool for Effective Exposure to 5-FU in Patients With Locally Advanced, Resectable Gastric or Gastro-oesophageal Junction Cancer Treated With Perioperative FLOT",[],"2023-12","2022-12-19",20,[371,372],"TDM of 5-FU","Pharmacokinetic Observational Study",[349],{"intervention":375,"totalTrials":52,"cells":376},"Spinal anesthesia",{"EARLY_PHASE1":377,"PHASE1":379,"PHASE2":381,"PHASE3":383,"PHASE4":385,"NA":387},{"trials":378,"activeCount":56},[],{"trials":380,"activeCount":56},[],{"trials":382,"activeCount":56},[],{"trials":384,"activeCount":56},[],{"trials":386,"activeCount":56},[],{"trials":388,"activeCount":56},[389],{"nctId":390,"briefTitle":391,"status":144,"phases":392,"primaryCompletion":393,"completion":393,"start":394,"enrollment":395,"conditions":396,"interventions":398},"NCT06711289","Predicting if the Blood Pressure Will Drop After Spinal Anesthesia Using Ultrasound of the Neck",[],"2023-09-29","2023-04-12",44,[397],"Spinal Anesthesia-induced Hypotension",[375],{"intervention":400,"totalTrials":52,"cells":401},"Gd-CA",{"EARLY_PHASE1":402,"PHASE1":404,"PHASE2":406,"PHASE3":408,"PHASE4":410,"NA":412},{"trials":403,"activeCount":56},[],{"trials":405,"activeCount":56},[],{"trials":407,"activeCount":56},[],{"trials":409,"activeCount":56},[],{"trials":411,"activeCount":56},[],{"trials":413,"activeCount":56},[414],{"nctId":415,"briefTitle":416,"status":144,"phases":417,"primaryCompletion":418,"completion":418,"start":419,"enrollment":420,"conditions":421,"interventions":423},"NCT02364193","Thoracic Fluid Assessment by Contrast-enhanced Magnetic Resonance Imaging and Bioimpedance",[49],"2015-06","2015-03",14,[422],"Pulmonary Congestion",[400],{"intervention":425,"totalTrials":52,"cells":426},"Phenylephrine",{"EARLY_PHASE1":427,"PHASE1":429,"PHASE2":431,"PHASE3":433,"PHASE4":435,"NA":437},{"trials":428,"activeCount":56},[],{"trials":430,"activeCount":56},[],{"trials":432,"activeCount":56},[],{"trials":434,"activeCount":56},[],{"trials":436,"activeCount":56},[],{"trials":438,"activeCount":56},[439],{"nctId":440,"briefTitle":441,"status":144,"phases":442,"primaryCompletion":443,"completion":443,"start":444,"enrollment":217,"conditions":445,"interventions":447},"NCT06374836","The Contractile Response of the Thoracic Aorta to Vasoactive Substances",[],"2024-10-31","2024-05-27",[446],"Human Thoracic Aorta Contractility",[425]]